Most Recent
Boral's former CEO Zlatko Tordorcevski and ex-CFO Tino La Spina have been granted discovery as they mull possible claims against their former employer for curbing their long-term incentive entitlements when they left in 2022.
Pharmacor, which is facing infringement claims by AstraZeneca over its plans to launch a generic version of diabetes drug Forxiga, can tweak its cross-claim to challenge a patent term extension.
Pharmacor has accused AstraZeneca of launching a royal commission into emails with its lawyers as AstraZeneca opposes the generic drug maker's bid to amend its pleading in a patent case over diabetes drug Forxiga.
Construction PRO
Corrs Chambers Westgarth has hired a leading projects partner from Ashurst who has significant experience in advising companies on the energy transition.
Deakin University has won an injunction barring a former professor from running his research business as 'Blue Carbon Lab', finding the university owns the associated trade marks.
Hugo Boss has won a challenge to the registration of a trade mark for 'AthleteBoss', with IP Australia finding the mark would likely cause confusion given the German fashion designer's reputation.
Construction PRO
A judge has tossed a suit seeking to recover a $1 million deposit on a $20.7 million agreement to purchase the former John Adjemis-owned Hotel Diplomat in Potts Point, after the deal fell through over concerns about mold and water ingress.
A judge has hit mattress retailer Emma Sleep with a $15 million penalty after it admitted to repeatedly misleading consumers about discounts, saying the ACCC's proposed $36 million was not needed to achieve deterrence.
ASIC has lost its case alleging software company Nuix failed to publish corrective disclosures that contradicted the growth story presented to the market in a prospectus for its $1.8 billion float on the ASX.
Gaming company Light & Wonder has been hit with a securities class action over disclosures about its Dragon Train poker game, after an employee's theft of rival Aristocrat's trade secrets led to litigation that settled for $190 million.